Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cadrenal Therapeutics Inc has a consensus price target of $3.5 based on the ratings of 2 analysts. The high is $4 issued by Noble Capital Markets on December 18, 2023. The low is $3 issued by HC Wainwright & Co. on June 6, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 6, 2024, May 9, 2024, and March 14, 2024, respectively. With an average price target of $3 between HC Wainwright & Co., there's an implied -57.14% downside for Cadrenal Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Cadrenal Therapeutics (NASDAQ:CVKD) was reported by HC Wainwright & Co. on June 6, 2024. The analyst firm set a price target for $3.00 expecting CVKD to fall to within 12 months (a possible -57.14% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Cadrenal Therapeutics (NASDAQ:CVKD) was provided by HC Wainwright & Co., and Cadrenal Therapeutics reiterated their buy rating.
There is no last upgrade for Cadrenal Therapeutics
There is no last downgrade for Cadrenal Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cadrenal Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cadrenal Therapeutics was filed on June 6, 2024 so you should expect the next rating to be made available sometime around June 6, 2025.
While ratings are subjective and will change, the latest Cadrenal Therapeutics (CVKD) rating was a reiterated with a price target of $3.00 to $3.00. The current price Cadrenal Therapeutics (CVKD) is trading at is $7.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.